7 research outputs found
Multi-wavelength Stellar Polarimetry of the Filamentary Cloud IC5146: I. Dust Properties
We present optical and near-infrared stellar polarization observations toward
the dark filamentary clouds associated with IC5146. The data allow us to
investigate the dust properties (this paper) and the magnetic field structure
(Paper II). A total of 2022 background stars were detected in -, -,
-, and/or -bands to mag. The ratio of the polarization
percentage at different wavelengths provides an estimate of ,
the wavelength of peak polarization, which is an indicator of the small-size
cutoff of the grain size distribution. The grain size distribution seems to
significantly change at 3 mag, where both the average and dispersion
of decrease. In addition, we found
0.6-0.9 m for mag, which is larger than the 0.55 m
in the general ISM, suggesting that grain growth has already started in low
regions. Our data also reveal that polarization efficiency (PE ) decreases with as a power-law in -, -, and
-bands with indices of -0.710.10, -1.230.10 and -0.530.09.
However, -band data show a power index change; the PE varies with
steeply (index of -0.950.30) when mag but softly
(index of -0.250.06) for greater values. The soft decay of PE in
high regions is consistent with the Radiative Aligned Torque model,
suggesting that our data trace the magnetic field to mag.
Furthermore, the breakpoint found in -band is similar to the where we
found the dispersion significantly decreased. Therefore, the
flat PE- in high regions implies that the power index changes result
from additional grain growth.Comment: 31 pages, 17 figures, and 3 tables; accepted for publication in Ap
D<sub>3</sub> blocks RHOA and ARF6 activation in destabilized endothelial cells.
<p>Endothelial cells were exposed to 10 μM D<sub>3</sub> or 7-DHC in combination with 2ng/mL TNF-α or IL-1β. Lysates were analyzed for RHOA-GTP and ARF6-GTP levels using appropriate precipitation assays. All graphs depict mean ± SEM. * denotes P<0.05, ** denotes P<0.01, and *** denotes P<0.001.</p
Vitamin D sterol activity.
<p>Graphical models of the different vitamin D3 sterols, their metabolism, and a summary of their normal circulating levels, the minimum active dose for stabilizing the endothelium and doses in which the sterols have been reported to interact with vitamin D receptor [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0140370#pone.0140370.ref029" target="_blank">29</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0140370#pone.0140370.ref051" target="_blank">51</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0140370#pone.0140370.ref052" target="_blank">52</a>]. *Normal circulating levels vary upon many conditions including diet and UV exposure.</p
D<sub>3</sub> stabilizes endothelial cells through a non-genomic mechanism.
<p><b>(A)</b> Endothelial cells were exposed to D<sub>3</sub> or its metabolites for 24 hours and lysates were probed for VDR transcription targets FOX01 and CYP24. Endothelial cells were exposed to D<sub>3</sub> or its metabolites in the presence of inhibitors of transcription (actinomycin D) and translation (cycloheximide) <b>(B, C)</b> and were assessed for transendothelial resistance or VDR target gene expression. All graphs depict mean ± SEM. * denotes P<0.05, and **** denotes P<0.0001. ### denotes P<0.001, and #### denotes P<0.0001 versus the respective control.</p
D<sub>3</sub> abrogates inflammatory leak in culture and <i>ex</i> vivo.
<p>Monolayers of HMVEC were stimulated with D<sub>3</sub> (10 μM), 7-DHC(10 μM), or 0.5% DMSO (vehicle control) in the presence of inflammatory cytokines: IL-1β (10 ng/mL), TNF-α (2 ng/mL), and LPS (100 ng/mL) in an (<b>A-C</b>) ECIS or (<b>D</b>) transwell leak assay. (<b>E</b>) VEGF-induced leak of a fluorescent reporter in arterioles isolated from wild-type mice fed either standard chow or a D<sub>3</sub>-enhanced chow. All panels depict mean ± SEM. * denotes P<0.05, ** denotes P<0.01, and **** denotes P<0.0001.</p
D<sub>3</sub> promotes VE-cadherin cell-cell junction stability.
<p>(<b>A</b>) Endothelial cells were treated with TNF-α and either 7-DHC or D<sub>3</sub> for the denoted times and lysates were immunoblotted for p731 VE-cadherin or total VE-Cadherin. (<b>B</b>) Endothelial cell monolayers were exposed to the denoted pro-inflammatory cues in the presence of vehicle control, D<sub>3</sub> or 7DHC. Cells were fixed and VE-Cadherin was visualized through immunofluorescent labeling with automated image acquisition and analysis. All graphs depict mean ± SEM. * denotes P<0.05, ** denotes P<0.01, and *** denotes P<0.001.</p
Vitamin D stabilizes the endothelium.
<p>Dose/time resistance (endothelial stability) surfaces generated with ECIS are shown from 100 pM to 10 μM and from zero to 21 hours for: (<b>A</b>) D<sub>3</sub>; (<b>F</b>) 25(OH)D<sub>3</sub>; (<b>K</b>) 1,25(OH)<sub>2</sub>D<sub>3</sub>. Detailed time-responses are shown at 1 nM and 10 μM respectively for: (<b>B</b> and <b>C)</b> D<sub>3</sub>; (<b>G</b> and <b>H</b>) 25(OH)D<sub>3</sub>; and (<b>L</b> and <b>M</b>) 1,25(OH)<sub>2</sub>D<sub>3</sub>. Detailed dose-response are shown at 4 hours and 12 hours respectively for (<b>D</b> and <b>E)</b> D<sub>3</sub>, (<b>I</b> and <b>J</b>) 25(OH)D<sub>3</sub>, and (<b>N</b> and <b>O</b>) 1,25(OH)<sub>2</sub>D<sub>3</sub>.</p